Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 300
- Avg volume
- —
- Day's range
- $4.25 – $4.25
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Development Technologies Corp. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergenc...
Show more
Development Technologies Corp. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. The company was formerly known as Pegasus Pharmaceuticals Inc. and changed its name to Development Technologies Corp. in April 2022. Development Technologies Corp. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 561-626-9901
- Address
- 4440 PGA Boulevard, Suite 308, Palm Beach Gardens, United States
Latest news
No headlines yet.
